NCT07022821 Comparison of Dexmedetomidine + Ketamine for Postoperative Pain in C-Section
| NCT ID | NCT07022821 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Fatima Memorial Hospital |
| Condition | Postoperative Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2025-05-16 |
| Primary Completion | 2025-08-16 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 90 participants in total. It began in 2025-05-16 with a primary completion date of 2025-08-16.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare three different doses of dexmedetomidine, when combined with a fixed dose of ketamine, for pain control in women undergoing cesarean section. The goal is to find the most effective combination with the fewest side effects.
Eligibility Criteria
Inclusion Criteria: * Elective lower segment cesarean section * American Society of Anesthesiologists (ASA) Physical Status II * Provided informed consent Exclusion Criteria: * Known drug allergy * Presence of significant comorbidities * Emergency surgery * Documented psychiatric illness
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07022821 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Postoperative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07022821 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT07022821 currently recruiting?
Yes, NCT07022821 is actively recruiting participants. Contact the research team at 2505.ahmed@gmail.com for enrollment information.
Where is the NCT07022821 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07022821 clinical trial?
NCT07022821 is sponsored by Fatima Memorial Hospital. The trial plans to enroll 90 participants.